Breathe BioMedical
Pre-clinicalWe are on a mission to revolutionize early cancer detection with our innovative breath analytics platform technology.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $6.7M
About
We are on a mission to revolutionize early cancer detection with our innovative breath analytics platform technology.
Diagnostics
Funding History
2Total raised:$6.7M
Series A$5.2MJun 15, 2021
Seed$1.5MJun 15, 2018